Literature DB >> 15998563

Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke?

Anton Ponholzer1, Christian Temml, Rudolf Obermayr, Clemens Wehrberger, Stephan Madersbacher.   

Abstract

BACKGROUND: Considered to be a manifestation of a generalized vascular disease, erectile dysfunction (ED) could serve as an indicator for future cardiovascular events. Aim of this study was therefore to evaluate the role of ED as a predictor for coronary heart disease (CHD) and stroke.
METHODS: Men participating in a health-screening project in the area of Vienna completed the International Index of Erectile Function-5 questionnaire (IIEF5) to assess prevalence and severity of ED. Additionally, all men underwent a detailed health examination. The risk for CHD or stroke within 10 years depending on the severity of ED was estimated according to Framingham risk profile algorithms.
RESULTS: In the CHD risk cohort (n = 2.495; 46.2 +/- 9.9 yrs) men with moderate/severe ED (IIEF5 5-16; n = 163) had a 65% increased relative risk for developing CHD within 10 yrs compared to those without ED (IIEF5 22-25; n = 1.784) (absolute risk: 8.0% for no ED to 13.2% for moderate/severe ED; p < 0.001). Relative risk increase ranged from 13.9% for those aged 30-39 yrs (p = 0.121), to 42.2% for 40-49 yrs (p = 0.012), 27.7% for 50-59 yrs (p = 0.048) and 27.1% for 60-69 yrs (p = 0.021). In the stroke risk population (n = 644; 61.3 +/- 5.1 yrs) men with moderate/severe ED (n = 99) were at a 43% relative risk increase for a stroke within 10 years (absolute risk: 9.3% for no ED to 13.3% for moderate/severe ED; p = 0.041). Increased risk varied between 38.6% for men aged 55-59 yrs (p = 0.013), 24.7% for 60-64 yrs (p = 0.072), 35.9% for 65-69 yrs (p = 0.046) and 43.6% for 70-74 yrs (p = 0.049).
CONCLUSIONS: Moderate to severe ED, but not mild ED is associated with a considerably increased risk for CHD or stroke within 10 years. A thorough medical surveillance seems therefore advisable for men with ED including cardiological evaluation, treatment of risk factors and lifestyle modifications.

Entities:  

Mesh:

Year:  2005        PMID: 15998563     DOI: 10.1016/j.eururo.2005.05.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  37 in total

1.  Significant improvement of erectile function after Roux-en-Y gastric bypass surgery in obese Chinese men with erectile dysfunction.

Authors:  Li Kun; Zhang Pin; Di Jianzhong; Han Xiaodong; Yu Haoyong; Bao Yuqian; Zhang Hongwei
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

2.  Erectile dysfunction: a vascular disease in the field of urology.

Authors:  Francois Bénard
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 3.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

4.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

5.  Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance.

Authors:  Eginhard Waldkirch; Stefan Uckert; Hüseyin Yildirim; Michael Sohn; Udo Jonas; Christian G Stief; Karl-Erik Andersson; Petter Hedlund
Journal:  World J Urol       Date:  2005-11-15       Impact factor: 4.226

Review 6.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

7.  A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors:  Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

8.  Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease.

Authors:  Babu Lal Meena; Dhanpat Kumar Kochar; Tulsi Das Agarwal; Raghvendra Choudhary; Abhishek Kochar
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

9.  Erectile dysfunction and mortality.

Authors:  Andre B Araujo; Thomas G Travison; Peter Ganz; Gretchen R Chiu; Varant Kupelian; Raymond C Rosen; Susan A Hall; John B McKinlay
Journal:  J Sex Med       Date:  2009-06-15       Impact factor: 3.802

10.  Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil.

Authors:  Amr Abdel Raheem; Philip Kell
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.